To confirm the utility of molecular testing of EGFR mutation in the sputum for lung cancer, sputum containing a known number of EGFR mutation-positive cells were artificially prepared, that is, HCC827 cells (exon19:E746-A750del) were mixed with cancer-negative sputum, and EGFR mutations were detected. This evidence concerns the gene EGFR and lung carcinoma.